Bendit Technologies Unveils FDA-Cleared Bendit17™ Microcatheter for Enhanced Vascular Procedures

Bendit Technologies Launches FDA-Cleared Bendit17™ Microcatheter

Bendit Technologies, an innovative player in the medical technology landscape, has officially announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its groundbreaking Bendit17™ microcatheter. This device, known for being the smallest steerable microcatheter on the market, promises to significantly enhance precision and accessibility in neurovascular and peripheral endovascular procedures.

This clearance represents a major leap forward for Bendit Technologies, enabling the company to introduce this pioneering technology to physicians and patients throughout the United States. Currently, Bendit is in the production phase, with plans to start its first commercial clinical procedures in the U.S. as early as January 2026. Moreover, the company is actively working towards obtaining additional regulatory approvals in various international markets.

A Game Changer in Vascular Procedures

Oz Cabiri, CEO of Bendit Technologies, emphasized the importance of this FDA clearance: "The approval of the Bendit17 is a major milestone for our team and a meaningful advancement for clinicians seeking greater control and navigational precision in complex vascular procedures. The device's ability to operate with or without a guidewire is a significant technological leap forward. Our goal is to redefine the possibilities in endovascular care, and the Bendit17 embodies that vision. We can't wait to provide this technology to physicians in the U.S. and enhance care for patients globally."

The Bendit17 microcatheter sets itself apart with advanced steerability and precision, allowing for controlled navigation through intricate anatomies. This capability facilitates the maintenance of stability, control, and ease of use, all critical for successful outcomes in complex vascular interventions. Furthermore, its unique design is tailored to meet the needs of clinicians across a wide range of challenging vascular procedures.

About Bendit Technologies

Founded with a vision to revolutionize medical procedures, Bendit Technologies focuses on developing advanced steerable microcatheters aimed at improving accuracy, accessibility, and efficiency in minimally invasive endovascular treatments. The company's proprietary 3D steering technology enhances navigability through complex anatomical structures, empowering clinicians and enhancing patient outcomes significantly.

With the FDA clearance of the Bendit17 microcatheter, Bendit Technologies is poised to make a substantial impact on the healthcare industry. Physicians can expect not only improved tools for their practice but also a higher level of care for their patients, further highlighting the essential role of innovation in medical device development.

As Bendit gears up for its U.S. launch and seeks additional global regulatory approvals, the medical community anticipates the potential transformations that the Bendit17 microcatheter will bring to vascular procedures worldwide.

For additional information on Bendit Technologies and the Bendit17 microcatheter, visit their official website or contact their media relations department.